MARKSANS PHARMA
|
The Current P/E Ratio of MARKSANS PHARMA is 36.97.
Share Price | ₹283.4 | Jan 08,2025 |
Market Cap | ₹12,843.7 Cr | |
Earnings-TTM | ₹347.4 Cr | TTM-Consolidated Results |
Price/Earnings | 36.97x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of MARKSANS PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹12,843.7 Cr] as on Jan 08,2025
(/) Earnings [ ₹347.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 36.97x ]
Thus, for MARKSANS PHARMA , the investors are currently willing to pay 36.97 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of MARKSANS PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of MARKSANS PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of MARKSANS PHARMA
PE Ratio Performance Analysis for MARKSANS PHARMA
- MARKSANS PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 11.50x.
- MARKSANS PHARMA 's operated at median p/e ratio of 10.1x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MARKSANS PHARMA 's p/e ratio peaked in Mar2024 at 21.89x.
- MARKSANS PHARMA 's p/e ratio hit its five-year low in Mar2020 of 4.86x.
How does MARKSANS PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
MARKSANS PHARMA | 347.44 | 36.97 | 12,843.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 39.58 | 440,830.0 |
CIPLA LTD | 4,485.22 | 26.92 | 120,742.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 21.15 | 114,366.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.97 | 98,766.9 |
DIVIS LABORATORIES LTD | 1,836.00 | 84.77 | 155,644.0 |
MANKIND PHARMA LTD | 2,124.86 | 55.86 | 118,687.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 62.45 | 112,542.0 |
LUPIN LTD | 2,651.94 | 38.75 | 102,762.0 |
AUROBINDO PHARMA LTD | 3,598.83 | 20.68 | 74,438.4 |
ABBOTT INDIA LTD | 1,284.66 | 48.92 | 62,845.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs MARKSANS PHARMA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 20.68x |
Max industry PE | 84.77x |
Median industry PE | 38.75x |
Average industry PE | 41.73x |
You may also like the below Video Courses